BANCA CREDIFARMA S.P.A.

Banca Credifarma S.p.A. is an Italian specialist bank focused on financial services for pharmacies and related healthcare retail businesses. The institution arose from the combination of Credifarma and Farbanca, creating a bank-level platform dedicated to the sector, and is majority-owned by Banca Ifis Group with a minority stake held by Federfarma. Its offering centers on working-capital lines, medium and long-term loans for the purchase or transfer of pharmacies, refurbishment and equipment, and the advance or factoring of receivables due from the National Health Service (SSN/ASL). It also provides business current accounts with online channels, POS/acquiring solutions, and ancillary services typical of SME banking; distribution is primarily direct and through relationships with pharmacists’ associations rather than a broad retail branch network. Credit assessment generally reflects prescription and OTC turnover, location metrics, and the quality and ageing of public-sector receivables; collateral can include pledges over business assets and personal guarantees, and facilities may make use of Italian SME guarantee schemes where available. The business model entails concentration in the pharmacy niche and exposure to public-sector payment timetables, so funding and liquidity management are relevant, particularly for receivables financing; pricing commonly references Euribor plus a spread, with fees and covenants varying by region and credit profile. As an Italian bank it operates under Bank of Italy supervision and, for eligible deposits, participates in the national deposit guarantee scheme in line with EU rules (coverage generally up to EUR 100,000 per depositor). Conditions, rates, and eligibility criteria are detailed in pre-contractual disclosures (foglio informativo/documento di sintesi) and can change; prospective clients should review current documentation and required financial information, including recent accounts and SSN receivables ageing, before applying.